1
|
A Nanoparticle's Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations. Cancers (Basel) 2022; 14:cancers14071741. [PMID: 35406513 PMCID: PMC8996837 DOI: 10.3390/cancers14071741] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 03/24/2022] [Accepted: 03/28/2022] [Indexed: 12/11/2022] Open
Abstract
Simple Summary Traditional cancer therapeutics suffer from off-target toxicity, limiting their effective dose and preventing patients’ tumors from being sufficiently treated by chemotherapeutics alone. Nanomedicine is an emerging class of therapeutics in which a drug is packaged into a nanoparticle that promotes uptake of the drug at a tumor site, shielding it from uptake by peripheral organs and enabling the safe delivery of chemotherapeutics that have poor aqueous solubility, short plasma half-life, narrow therapeutic window, and toxic side effects. Despite the advantages of nanomedicines for cancer, there remains significant challenges to improve uptake at the tumor and prevent premature clearance from the body. In this review, we summarize the effects of first-pass metabolism on a nanoparticle’s journey to a tumor and outline future steps that we believe will improve the efficacy of cancer nanomedicines. Abstract Nanomedicines represent the cutting edge of today’s cancer therapeutics. Seminal research decades ago has begun to pay dividends in the clinic, allowing for the delivery of cancer drugs with enhanced systemic circulation while also minimizing off-target toxicity. Despite the advantages of delivering cancer drugs using nanoparticles, micelles, or other nanostructures, only a small fraction of the injected dose reaches the tumor, creating a narrow therapeutic window for an otherwise potent drug. First-pass metabolism of nanoparticles by the reticuloendothelial system (RES) has been identified as a major culprit for the depletion of nanoparticles in circulation before they reach the tumor site. To overcome this, new strategies, materials, and functionalization with stealth polymers have been developed to improve nanoparticle circulation and uptake at the tumor site. This review summarizes the strategies undertaken to evade RES uptake of nanomedicines and improve the passive and active targeting of nanoparticle drugs to solid tumors. We also outline the limitations of current strategies and the future directions we believe will be explored to yield significant benefits to patients and make nanomedicine a promising treatment modality for cancer.
Collapse
|
2
|
Marcos X, Méndez-Luna D, Fragoso-Vázquez M, Rosales-Hernández M, Correa-Basurto J. Anti-breast cancer activity of novel compounds loaded in polymeric mixed micelles: Characterization and in vitro studies. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2021.102815] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
Cicuéndez M, Coimbra A, Santos J, Oliveira H, Ayán−Varela M, Paredes JI, Villar−Rodil S, Vila M, Silva VS. Cytotoxicity of Nucleotide-Stabilized Graphene Dispersions on Osteosarcoma and Healthy Cells: On the Way to Safe Theranostics Agents. ACS APPLIED BIO MATERIALS 2021; 4:4384-4393. [DOI: 10.1021/acsabm.1c00144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Mónica Cicuéndez
- CICECO, Aveiro Institute of Materials, Chemistry Department, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
- NRG-TEMA, Mechanical Engineering Department, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193 , Portugal
| | - Andreia Coimbra
- CESAM & Department of Biology, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
| | - Joana Santos
- CESAM & Department of Biology, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
| | - Helena Oliveira
- CICECO, Aveiro Institute of Materials, Chemistry Department, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
- CESAM & Department of Biology, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
| | - Miguel Ayán−Varela
- Instituto de Ciencia y Tecnología del Carbono, INCAR-CSIC, C/Francisco Pintado Fe 26, Oviedo 33011, Spain
| | - Juan Ignacio. Paredes
- Instituto de Ciencia y Tecnología del Carbono, INCAR-CSIC, C/Francisco Pintado Fe 26, Oviedo 33011, Spain
| | - Sílvia Villar−Rodil
- Instituto de Ciencia y Tecnología del Carbono, INCAR-CSIC, C/Francisco Pintado Fe 26, Oviedo 33011, Spain
| | - Mercedes Vila
- NRG-TEMA, Mechanical Engineering Department, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193 , Portugal
| | - Virgília Sofia Silva
- CESAM & Department of Biology, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal
| |
Collapse
|
4
|
Terracciano R, Demarchi D, Ruo Roch M, Aiassa S, Pagana G. Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY 2021; 21:2760-2777. [PMID: 33653442 DOI: 10.1166/jnn.2021.19061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
In recent years the worldwide research community has highlighted innumerable benefits of nanomaterials in cancer detection and therapy. Nevertheless, the development of cancer nanomedicines and other bionanotechnology requires a huge amount of considerations about the interactions of nanomaterials and biological systems, since long-term effects are not yet fully known. Open issues remain the determination of the nanoparticles distributions patterns and the internalization rate into the tumor while avoiding their accumulation in internal organs or other healthy tissues. The purpose of this work is to provide a standard overview of the most recent advances in nanomaterials to fight cancer and to collect trends and future directions to follow according to some critical aspects still present in this field. Complementary to the very recent review of Wolfram and Ferrari which discusses and classifies successful clinically-approved cancer nanodrugs as well as promising candidates in the pipeline, this work embraces part of their proposed classification system based on the exploitation of multifunctionality and extends the review to peer-reviewed journal articles published in the last 3 years identified through international databases.
Collapse
Affiliation(s)
- Rossana Terracciano
- Department of Electronics and Telecommunications (DET), Politecnico di Torino, 10129, Italy
| | - Danilo Demarchi
- Department of Electronics and Telecommunications (DET), Politecnico di Torino, 10129, Italy
| | - Massimo Ruo Roch
- Department of Electronics and Telecommunications (DET), Politecnico di Torino, 10129, Italy
| | - Simone Aiassa
- Department of Electronics and Telecommunications (DET), Politecnico di Torino, 10129, Italy
| | - Guido Pagana
- Department of Electronics and Telecommunications (DET), Politecnico di Torino, 10129, Italy
| |
Collapse
|
5
|
Allen J, Wang J, Zolotarskaya OY, Sule A, Mohammad S, Arslan S, Wynne KJ, Yang H, Valerie K. PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer. J Control Release 2020; 321:36-48. [PMID: 32027939 DOI: 10.1016/j.jconrel.2020.02.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 01/26/2020] [Accepted: 02/02/2020] [Indexed: 12/12/2022]
Abstract
Glioblastoma multiforme (GBM) is an aggressive and difficult to treat form of brain cancer. In this work, we report on a novel chronotherapeutic polymeric drug, PEAMOtecan, for GBM therapy. PEAMOtecan was synthesized by conjugating camptothecin, a topoisomerase I inhibitor, to our proprietary, 'clickable' and modular polyoxetane polymer platform consisting of acetylene-functionalized 3-ethyl-3-(hydroxymethyl)oxetane (EAMO) repeat units (Patent No.: US 9,421,276) via the linker 3,3'-dithiodipropionic acid (DDPA) with a disulfide bond (SS) extended by short-chain polyethylene glycol (PEG). We show that PEAMOtecan is a highly modular polymer nanoformulation that protects covalently bound CPT until slowly being released over extended periods of time dependent on the cleavage of the disulfide and ester linkages. PEAMOtecan kills glioma cells by mitotic catastrophe with p53 mutant/knockdown cells being more sensitive than matched wild type cells potentially providing cancer-specific targeting. To establish proof-of-principle therapeutic effects, we tested PEAMOtecan as monotherapy for efficacy in a mouse orthotopic glioma model. PEAMOtecan was administered by one-time, convection-enhanced delivery (CED) intra-tumorally to achieve superior distribution and extended drug release over time. In addition, the near-infrared (NIR) dye Cy5.5 was coupled to the polymer providing live-animal imaging capability to track tissue distribution and clearance of the injected polymer over time. We show that PEAMOtecan significantly improves the survival of mice harboring intra-cranial tumors (p = .0074 compared to untreated group). Altogether, these results support further development and testing of our nanoconjugate platform.
Collapse
Affiliation(s)
- Jasmine Allen
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Juan Wang
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Olga Yu Zolotarskaya
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Amrita Sule
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Sajjad Mohammad
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Shukaib Arslan
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Kenneth J Wynne
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America
| | - Hu Yang
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America.
| | - Kristoffer Valerie
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, United States of America.
| |
Collapse
|
6
|
Murugan C, Sharma V, Murugan RK, Malaimegu G, Sundaramurthy A. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy. J Control Release 2019; 299:1-20. [DOI: 10.1016/j.jconrel.2019.02.015] [Citation(s) in RCA: 77] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2018] [Revised: 02/11/2019] [Accepted: 02/12/2019] [Indexed: 02/07/2023]
|
7
|
Mazumder A, Assawapanumat W, Dwivedi A, Reabroi S, Chairoungdua A, Nasongkla N. Glucose targeted therapy against liver hepatocellular carcinoma: In vivo study. J Drug Deliv Sci Technol 2019. [DOI: 10.1016/j.jddst.2018.12.036] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
8
|
Yoncheva K, Tzankova V, Yordanov Y, Tzankov B, Grancharov G, Aluani D, Bankova V, Popova M, Trusheva B, Kondeva-Burdina M, Petrov P. Evaluation of antioxidant activity of caffeic acid phenethyl ester loaded block copolymer micelles. BIOTECHNOL BIOTEC EQ 2019. [DOI: 10.1080/13102818.2018.1537753] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Affiliation(s)
- Krassimira Yoncheva
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Virginia Tzankova
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Yordan Yordanov
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Borislav Tzankov
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Georgy Grancharov
- Institute of Polymers, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Denitsa Aluani
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Vassya Bankova
- Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Milena Popova
- Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Boryana Trusheva
- Institute of Organic Chemistry with Center for Phytochemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Magdalena Kondeva-Burdina
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
| | - Petar Petrov
- Institute of Polymers, Bulgarian Academy of Sciences, Sofia, Bulgaria
| |
Collapse
|
9
|
Mei L, Xu K, Zhai Z, He S, Zhu T, Zhong W. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery. Org Biomol Chem 2019; 17:3853-3860. [DOI: 10.1039/c9ob00046a] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Doxorubicin reinforced the self-assembly of RGD-derived peptide conjugates responsive to mild acidity.
Collapse
Affiliation(s)
- Leixia Mei
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
| | - Keming Xu
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
- Key Laboratory of Biomedical Functional Materials
| | - Ziran Zhai
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
| | - Suyun He
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
| | - Tingting Zhu
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
| | - Wenying Zhong
- Department of Analytical Chemistry
- China Pharmaceutical University
- Nanjing
- P. R. China
- Key Laboratory of Biomedical Functional Materials
| |
Collapse
|
10
|
Marcos X, Padilla-Beltrán C, Bernad-Bernad MJ, Rosales-Hernández MC, Pérez-Casas S, Correa-Basurto J. Controlled release of N-(2-hydroxyphenyl)-2-propylpentanamide nanoencapsulated in polymeric micelles of P123 and F127 tested as anti-proliferative agents in MDA-MB-231 cells. J Drug Deliv Sci Technol 2018. [DOI: 10.1016/j.jddst.2018.10.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
11
|
Khan AR, Yang X, Fu M, Zhai G. Recent progress of drug nanoformulations targeting to brain. J Control Release 2018; 291:37-64. [DOI: 10.1016/j.jconrel.2018.10.004] [Citation(s) in RCA: 78] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Revised: 10/03/2018] [Accepted: 10/04/2018] [Indexed: 02/08/2023]
|
12
|
Din FU, Saleem S, Aleem F, Ahmed R, Huda NU, Ahmed S, Khaleeq N, Shah KU, Ullah I, Zeb A, Aman W. Advanced colloidal technologies for the enhanced bioavailability of drugs. COGENT MEDICINE 2018. [DOI: 10.1080/2331205x.2018.1480572] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Open
Affiliation(s)
- Fakhar ud Din
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Sehrish Saleem
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Fatima Aleem
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Rida Ahmed
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Noor ul Huda
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Sohail Ahmed
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | - Nadra Khaleeq
- Department of Pharmacy, Quaid-I-Azam University, Islamabad, Pakistan
| | | | - Izhar Ullah
- Department of Pharmacy, University of Poonch Rawlakot AJK, Rawlakot, Pakistan
| | - Alam Zeb
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
| | - Waqar Aman
- Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan
| |
Collapse
|
13
|
Liu Z, Liu J, Wang T, Li Q, Francis PS, Barrow CJ, Duan W, Yang W. Switching off the interactions between graphene oxide and doxorubicin using vitamin C: combining simplicity and efficiency in drug delivery. J Mater Chem B 2018; 6:1251-1259. [DOI: 10.1039/c7tb03063k] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Delivery of doxorubicin using graphene oxide is remarkably improved by adding a little amount of vitamin C.
Collapse
Affiliation(s)
- Zhen Liu
- Centre for Chemistry and Biotechnology
- School of Life and Environmental Sciences
- Deakin University
- Geelong
- Australia
| | - Jingquan Liu
- College of Chemical Science and Engineering
- Laboratory of Fiber Materials and Modern Textile
- The Growing Base for State Key Laboratory
- Qingdao University
- Qingdao
| | - Tao Wang
- School of Nursing
- Zhengzhou University
- Zhengzhou
- China
- School of Medicine
| | - Qiong Li
- School of Medicine
- Faculty of Health
- Deakin University
- Geelong
- Australia
| | - Paul S. Francis
- Centre for Chemistry and Biotechnology
- School of Life and Environmental Sciences
- Deakin University
- Geelong
- Australia
| | - Colin J. Barrow
- Centre for Chemistry and Biotechnology
- School of Life and Environmental Sciences
- Deakin University
- Geelong
- Australia
| | - Wei Duan
- School of Medicine
- Faculty of Health
- Deakin University
- Geelong
- Australia
| | - Wenrong Yang
- Centre for Chemistry and Biotechnology
- School of Life and Environmental Sciences
- Deakin University
- Geelong
- Australia
| |
Collapse
|
14
|
An industry update: the latest developments in therapeutic delivery. Ther Deliv 2017; 8:827-832. [PMID: 28944738 DOI: 10.4155/tde-2017-0074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The present industry update covers the period 1-30 June 2017, with information sourced from company press releases, regulatory and patent agencies as well as scientific literature. The combination of drug and devices such as improved, safer injectables (see various market reports, companies Adamis and Baxter), patches (Microdermis) and (nano)carriers are moving increasingly from the R&D stage into clinical trials and toward the market. This addresses increased safety and effectiveness requirements, limiting physico-chemical properties of active ingredients, cost-effectiveness and patient comfort through ease of use. Further attention in the market is on local delivery methods (such as intraocular by Icon Bioscience, Glaukos) and the sheer infinite possibilities of nanotechnology such as LDL nanocarriers, microneedles and hydrogel cubes. Another 21st century key technology area is mobile applications (Vital Art and Science) and connected devices (SmartPill, Pop Test Devices) which are increasingly finding their way into the drug delivery field to enable, for example, closed loop monitoring of drug dosing in trials and of patients with their care providers. Not surprisingly companies are increasingly utilizing convergence to combine their diverse capabilities (Vetter Pharma/Microdermis, TXCell/Lentigen Technology).
Collapse
|
15
|
|
16
|
Wakaskar RR. General overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. J Drug Target 2017; 26:311-318. [DOI: 10.1080/1061186x.2017.1367006] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Rajesh R. Wakaskar
- Research and Development, Insys Development Company Inc., Chandler, AZ, USA
| |
Collapse
|